- Home
- WIA vs DRTS Comparison
WIA vs DRTS Comparison
Compare WIA & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- DRTS
- Stock Information
- Founded
- WIA 2003
- DRTS 2015
- Country
- WIA United States
- DRTS Israel
- Employees
- WIA N/A
- DRTS N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- DRTS Medical/Dental Instruments
- Sector
- WIA Finance
- DRTS Health Care
- Exchange
- WIA Nasdaq
- DRTS Nasdaq
- Market Cap
- WIA 188.0M
- DRTS 211.7M
- IPO Year
- WIA N/A
- DRTS N/A
- Fundamental
- Price
- WIA $8.14
- DRTS $2.57
- Analyst Decision
- WIA
- DRTS Strong Buy
- Analyst Count
- WIA 0
- DRTS 2
- Target Price
- WIA N/A
- DRTS $8.00
- AVG Volume (30 Days)
- WIA 39.2K
- DRTS 28.0K
- Earning Date
- WIA 01-01-0001
- DRTS 05-19-2025
- Dividend Yield
- WIA 12.29%
- DRTS N/A
- EPS Growth
- WIA N/A
- DRTS N/A
- EPS
- WIA N/A
- DRTS N/A
- Revenue
- WIA N/A
- DRTS N/A
- Revenue This Year
- WIA N/A
- DRTS N/A
- Revenue Next Year
- WIA N/A
- DRTS N/A
- P/E Ratio
- WIA N/A
- DRTS N/A
- Revenue Growth
- WIA N/A
- DRTS N/A
- 52 Week Low
- WIA $7.56
- DRTS $1.75
- 52 Week High
- WIA $8.91
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- WIA 43.53
- DRTS 46.76
- Support Level
- WIA $8.08
- DRTS $2.52
- Resistance Level
- WIA $8.18
- DRTS $2.61
- Average True Range (ATR)
- WIA 0.08
- DRTS 0.11
- MACD
- WIA -0.01
- DRTS 0.02
- Stochastic Oscillator
- WIA 30.00
- DRTS 87.10
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.